Moreover, the activation of Golgi Arf-like protein 1 (ARL1) is facilitated by synaptotagmin 1 (SYT1) [30], with ARL1 independently serving as a prognostic determinant for cutaneous melanoma, as higher ARL1 levels correspond to improved prognosis [31]. The gene discussed is SYT1; the disease is cutaneous melanoma.